Buy or sell Vineti stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Vineti Stock

Vineti is a pioneering cell and gene therapy software and analytics company.

About Vineti Stock

Vineti is the first commercial cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of 21st century medicine. The Vineti platform integrates logistics, manufacturing and clinical data to improve product performance overall. Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there’s an opportunity to provide greater health outcomes—and cures—to patients in need.

Funding History

June 2017$13.8M
April 2018$33.5M


Chief Strategy Officer

Heidi M. Hagen


Razmik Abnous

Chief Science Officer

Malek Faham

SVP Finance & Operations

Chris Krueger

CO-Founder and Chief Executive Officer

Amy DuRoss

VP, Software Products

Nerses Ohanyan

Co-founder & Director of Marketing

Stephen Ting


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Vineti or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 90K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: